Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
Transition
Report Pursuant to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
Commission
File Number: 1-9819
|
Virginia
|
52-1549373
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
incorporation
or organization)
|
Identification
No.)
|
4991
Lake Brook Drive, Suite 100, Glen Allen, Virginia
|
23060-9245
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(804)
217-5800
(Registrant’s
telephone number, including area code)
|
Large
accelerated filer
|
o
|
Accelerated
filer
|
þ
|
Non-accelerated
filer
|
o (Do
not check if a smaller reporting company)
|
Smaller reporting
company
|
o
|
Page
|
|||
PART
I.
|
FINANCIAL
INFORMATION
|
||
Item
1.
|
Financial
Statements
|
||
Condensed
Consolidated Balance Sheets at September 30, 2009 (unaudited) and December
31, 2008
|
1
|
||
Condensed
Consolidated Statements of Operations for the three and nine months ended
September 30, 2009 and September 30,
2008 (unaudited)
|
2
|
||
Condensed
Consolidated Statements of Shareholders’ Equity for the nine months ended
September 30, 2009 and September 30, 2008 (unaudited)
|
3
|
||
Condensed
Consolidated Statements of Cash Flows for the nine months ended September
30, 2009 and September 30, 2008 (unaudited)
|
4
|
||
Notes
to Unaudited Condensed Consolidated Financial Statements
|
5
|
||
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
23
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
47
|
|
Item
4.
|
Controls
and Procedures
|
53
|
|
PART
II.
|
OTHER
INFORMATION
|
||
Item
1.
|
Legal
Proceedings
|
54
|
|
Item
1A.
|
Risk
Factors
|
55
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
55
|
|
Item
3.
|
Defaults
Upon Senior Securities
|
55
|
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
55
|
|
Item
5.
|
Other
Information
|
55
|
|
Item
6.
|
Exhibits
|
56
|
|
SIGNATURES
|
57
|
September
30,
|
December
31,
|
|||||||
2009
|
2008
|
|||||||
(unaudited)
|
||||||||
ASSETS
|
||||||||
Agency
MBS (including pledged Agency MBS of $552,970 and $300,277 at
September 30, 2009 and December 31, 2008, respectively)
|
$ | 600,927 | $ | 311,576 | ||||
Securitized
mortgage loans, net
|
225,731 | 243,827 | ||||||
Investment
in joint venture
|
8,174 | 5,655 | ||||||
Other
investments, net
|
8,439 | 12,735 | ||||||
843,271 | 573,793 | |||||||
Cash
and cash equivalents
|
21,749 | 24,335 | ||||||
Restricted
cash
|
– | 2,974 | ||||||
Other
assets
|
7,526 | 6,089 | ||||||
$ | 872,546 | $ | 607,191 | |||||
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
||||||||
Liabilities:
|
||||||||
Repurchase
agreements
|
$ | 545,761 | $ | 274,217 | ||||
Securitization
financing
|
148,184 | 178,165 | ||||||
Obligation
under payment agreement
|
9,095 | 8,534 | ||||||
Other
liabilities
|
5,745 | 5,866 | ||||||
708,785 | 466,782 | |||||||
Commitments
and Contingencies (Note 13)
|
||||||||
Shareholders’
equity:
|
||||||||
Preferred
stock, par value $0.01 per share: 50,000,000 shares authorized, 9.5%
Cumulative Convertible Series D; 4,221,539 shares issued and outstanding
($43,218 aggregate liquidation preference)
|
41,749 | 41,749 | ||||||
Common
stock, par value $0.01 per share, 100,000,000 shares authorized,
13,572,012 and 12,169,762 shares issued and outstanding,
respectively
|
136 | 122 | ||||||
Additional
paid-in capital
|
376,659 | 366,817 | ||||||
Accumulated
other comprehensive income (loss)
|
7,999 | (3,949 | ) | |||||
Accumulated
deficit
|
(262,782 | ) | (264,330 | ) | ||||
163,761 | 140,409 | |||||||
$ | 872,546 | $ | 607,191 | |||||
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30,
|
September
30,
|
|||||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
Interest
income:
|
||||||||||||||||
Investments
|
$ | 9,448 | $ | 7,719 | $ | 28,735 | $ | 20,375 | ||||||||
Cash and cash
equivalents
|
4 | 158 | 13 | 659 | ||||||||||||
9,452 | 7,877 | 28,748 | 21,034 | |||||||||||||
Interest
expense
|
(2,855 | ) | (5,090 | ) | (11,226 | ) | (13,325 | ) | ||||||||
Net
interest income
|
6,597 | 2,787 | 17,522 | 7,709 | ||||||||||||
Provision
for loan losses
|
(248 | ) | (449 | ) | (566 | ) | (796 | ) | ||||||||
Net
interest income after provision for loan losses
|
6,349 | 2,338 | 16,956 | 6,913 | ||||||||||||
Equity
in income (loss) of joint venture
|
1,620 | (3,462 | ) | 1,476 | (5,153 | ) | ||||||||||
Gain
on sale of investments, net
|
– | 331 | 220 | 2,381 | ||||||||||||
Fair
value adjustments, net
|
(457 | ) | 1,461 | (319 | ) | 5,519 | ||||||||||
Other
income
|
29 | 3,862 | 193 | 6,954 | ||||||||||||
General
and administrative expenses:
|
||||||||||||||||
Compensation and
benefits
|
(824 | ) | (609 | ) | (2,776 | ) | (1,693 | ) | ||||||||
Other general and
administrative expenses
|
(715 | ) | (876 | ) | (2,245 | ) | (2,261 | ) | ||||||||
Net
income
|
6,002 | 3,045 | 13,505 | 12,660 | ||||||||||||
Preferred
stock dividends
|
(1,003 | ) | (1,003 | ) | (3,008 | ) | (3,008 | ) | ||||||||
Net
income to common shareholders
|
$ | 4,999 | $ | 2,042 | $ | 10,497 | $ | 9,652 | ||||||||
Weighted
average common shares:
|
||||||||||||||||
Basic
|
13,552 | 12,170 | 12,908 | 12,165 | ||||||||||||
Diluted
|
17,776 | 12,173 | 17,131 | 16,393 | ||||||||||||
Net
income per common share:
|
||||||||||||||||
Basic
|
$ | 0.37 | $ | 0.17 | $ | 0.81 | $ | 0.79 | ||||||||
Diluted
|
$ | 0.34 | $ | 0.17 | $ | 0.79 | $ | 0.77 | ||||||||
Dividends
declared per common share
|
$ | 0.23 | $ | 0.23 | $ | 0.69 | $ | 0.48 |
Preferred
Stock
|
Common
Stock
|
Additional
Paid-in
Capital
|
Accumulated
Other
Comprehensive
(Loss)
Income
|
Accumulated
Deficit
|
Total
|
|||||||||||||||||||
Balance
at December 31, 2008
|
$ | 41,749 | $ | 122 | $ | 366,817 | $ | (3,949 | ) | $ | (264,330 | ) | $ | 140,409 | ||||||||||
Net
income
|
– | – | – | – | 13,505 | 13,505 | ||||||||||||||||||
Other
comprehensive income:
|
||||||||||||||||||||||||
Change
in market value of securities and other investments
|
– | – | – | 11,461 | – | 11,461 | ||||||||||||||||||
Reclassification
adjustment for joint venture’s other-than-temporary
impairment
|
– | – | – | 707 | – | 707 | ||||||||||||||||||
Reclassification
adjustment for gain on sale of investments, net included in net
income
|
– | – | – | (220 | ) | – | (220 | ) | ||||||||||||||||
Total
comprehensive income
|
25,453 | |||||||||||||||||||||||
Dividends
on common stock
|
– | – | – | – | (8,949 | ) | (8,949 | ) | ||||||||||||||||
Dividends
on preferred stock
|
– | – | – | – | (3,008 | ) | (3,008 | ) | ||||||||||||||||
Common
stock issuance
|
– | 14 | 9,759 | – | – | 9,773 | ||||||||||||||||||
Vesting
of restricted stock
|
– | – | 83 | – | – | 83 | ||||||||||||||||||
Balance
at September 30, 2009
|
$ | 41,749 | $ | 136 | $ | 376,659 | $ | 7,999 | $ | (262,782 | ) | $ | 163,761 |
Preferred
Stock
|
Common
Stock
|
Additional
Paid-in
Capital
|
Accumulated
Other
Comprehensive
(Loss)
Income
|
Accumulated
Deficit
|
Total
|
|||||||||||||||||||
Balance
at December 31, 2007
|
$ | 41,749 | $ | 121 | $ | 366,716 | $ | 1,093 | $ | (267,743 | ) | $ | 141,936 | |||||||||||
Cumulative
effect of adoption of SFAS 159
|
– | – | – | – | 943 | 943 | ||||||||||||||||||
Net
income
|
– | – | – | – | 12,660 | 12,660 | ||||||||||||||||||
Other
comprehensive income:
|
||||||||||||||||||||||||
Change
in market value of securities and other investments
|
– | – | – | (4,753 | ) | – | (4,753 | ) | ||||||||||||||||
Reclassification
adjustment for gain on sale of investments, net included in net
income
|
– | – | – | (2,381 | ) | – | (2,381 | ) | ||||||||||||||||
Total
comprehensive income
|
5,526 | |||||||||||||||||||||||
Dividends
on common stock
|
– | – | – | – | (5,841 | ) | (5,841 | ) | ||||||||||||||||
Dividends
on preferred stock
|
– | – | – | – | (3,008 | ) | (3,008 | ) | ||||||||||||||||
Stock
option issuance
|
– | – | 13 | – | – | 13 | ||||||||||||||||||
Grant
and vesting of restricted stock
|
– | 1 | 64 | – | – | 65 | ||||||||||||||||||
Balance
at September 30, 2008
|
$ | 41,749 | $ | 122 | $ | 366,793 | $ | (6,041 | ) | $ | (262,989 | ) | $ | 139,634 |
|
DYNEX
CAPITAL, INC.
|
|
OF CASH FLOWS
(UNAUDITED)
|
|
(amounts
in thousands)
|
Nine
Months Ended
|
||||||||
September
30,
|
||||||||
2009
|
2008
|
|||||||
Operating
activities:
|
||||||||
Net
income
|
$ | 13,505 | $ | 12,660 | ||||
Adjustments
to reconcile net income to cash provided by operating
activities:
|
||||||||
Equity
in (income) loss of joint venture
|
(1,476 | ) | 5,153 | |||||
Provision
for loan losses
|
566 | 796 | ||||||
Gain
on sale of investments, net
|
(220 | ) | (2,381 | ) | ||||
Fair
value adjustments, net
|
319 | (5,519 | ) | |||||
Amortization
and depreciation
|
1,812 | (1,694 | ) | |||||
Stock
based compensation expense (benefit)
|
426 | (263 | ) | |||||
Net
change in other assets and other liabilities
|
(2,645 | ) | (4,134 | ) | ||||
Net
cash provided by operating activities
|
12,287 | 4,618 | ||||||
Investing
activities:
|
||||||||
Principal
payments received on securitized mortgage loans
|
17,332 | 28,008 | ||||||
Purchases
of Agency MBS
|
(364,575 | ) | (343,941 | ) | ||||
Purchases
of other investments
|
– | (9,988 | ) | |||||
Payments
received on Agency MBS and other investments
|
86,448 | 21,171 | ||||||
Proceeds
from sales of other investments
|
3,699 | 19,188 | ||||||
Proceeds
from sales of Agency MBS
|
– | 29,744 | ||||||
Other
|
(1,796 | ) | (2,882 | ) | ||||
Net
cash used by investing activities
|
(258,892 | ) | (258,700 | ) | ||||
Financing
activities:
|
||||||||
Net
borrowings under repurchase agreements
|
271,544 | 261,207 | ||||||
Principal
payments on securitization financing
|
(13,256 | ) | (17,217 | ) | ||||
Decrease
in restricted cash
|
2,974 | – | ||||||
Redemption
of securitization financing
|
(15,493 | ) | – | |||||
Proceeds
from issuance of common stock
|
9,884 | – | ||||||
Dividends
paid
|
(11,634 | ) | (8,849 | ) | ||||
Net
cash provided by financing activities
|
244,019 | 235,141 | ||||||
Net
decrease in cash and cash equivalents
|
(2,586 | ) | (18,941 | ) | ||||
Cash
and cash equivalents at beginning of period
|
24,335 | 35,352 | ||||||
Cash
and cash equivalents at end of period
|
$ | 21,749 | $ | 16,411 | ||||
Supplemental
disclosure of non-cash financing activities:
|
||||||||
Dividends declared and
unpaid
|
$ | 4,125 | $ | 3,802 | ||||
Three
Months Ended September 30,
|
||||||||||||||||
2009
|
2008
|
|||||||||||||||
Income
|
Weighted-Average
Common Shares
|
Income
|
Weighted-
Average
Common
Shares
|
|||||||||||||
Net
income
|
$ | 6,002 | $ | 3,045 | ||||||||||||
Preferred
stock dividends
|
(1,003 | ) | (1,003 | ) | ||||||||||||
Net
income to common shareholders
|
4,999 | 13,551,994 | 2,042 | 12,169,762 | ||||||||||||
Effect
of dilutive items
|
1,003 | 4,224,346 | – | 2,761 | ||||||||||||
Diluted
|
$ | 6,002 | 17,776,340 | $ | 2,042 | 12,172,523 | ||||||||||
Net
income per common share:
|
||||||||||||||||
Basic
|
$ | 0.37 | $ | 0.17 | ||||||||||||
Diluted
|
$ | 0.34 | $ | 0.17 | ||||||||||||
Reconciliation
of shares included in calculation of net income per common share due to
dilutive effect:
|
||||||||||||||||
Net
effect of dilutive:
|
||||||||||||||||
Convertible
preferred stock
|
$ | 1,003 | 4,221,539 | $ | – | – | ||||||||||
Stock
options
|
– | 2,807 | – | 2,761 | ||||||||||||
$ | 1,003 | 4,224,346 | $ | – | 2,761 |
Nine
Months Ended September 30,
|
||||||||||||||||
2009
|
2008
|
|||||||||||||||
Income
|
Weighted-Average
Common Shares
|
Income
|
Weighted-
Average
Common
Shares
|
|||||||||||||
Net
income
|
$ | 13,505 | $ | 12,660 | ||||||||||||
Preferred
stock dividends
|
(3,008 | ) | (3,008 | ) | ||||||||||||
Net
income to common shareholders
|
10,497 | 12,908,243 | 9,652 | 12,165,483 | ||||||||||||
Effect
of dilutive items
|
3,008 | 4,222,306 | 3,008 | 4,227,296 | ||||||||||||
Diluted
|
$ | 13,505 | 17,130,549 | $ | 12,660 | 16,392,779 | ||||||||||
Net
income common per share:
|
||||||||||||||||
Basic
|
$ | 0.81 | $ | 0.79 | ||||||||||||
Diluted
|
$ | 0.79 | $ | 0.77 | ||||||||||||
Reconciliation
of shares included in calculation of net income per common share due to
dilutive effect:
|
||||||||||||||||
Net
effect of dilutive:
|
||||||||||||||||
Convertible
preferred stock
|
$ | 3,008 | 4,221,539 | $ | 3,008 | 4,221,539 | ||||||||||
Stock
options
|
– | 767 | – | 5,757 | ||||||||||||
$ | 3,008 | 4,222,306 | $ | 3,008 | 4,227,296 |
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30,
|
September
30,
|
|||||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
Shares
issuable under stock option awards
|
70,000 | 85,000 | 70,000 | 50,000 | ||||||||||||
Convertible
preferred stock
|
– | 4,221,539 | – | – |
September
30,
2009
|
December
31, 2008
|
|||||||
Principal/par
value
|
$ | 576,573 | $ | 307,548 | ||||
Purchase
premiums
|
12,993 | 3,585 | ||||||
Purchase
discounts
|
(46 | ) | (59 | ) | ||||
Amortized cost
|
589,520 | 311,074 | ||||||
Gross
unrealized gains
|
11,531 | 1,355 | ||||||
Gross
unrealized losses
|
(124 | ) | (853 | ) | ||||
Fair value
|
$ | 600,927 | $ | 311,576 | ||||
Weighted
average coupon
|
4.90 | % | 5.06 | % | ||||
Weighted
average months to reset
|
20 | 21 |
September
30,
2009
|
December
31, 2008
|
|||||||
Securitized
mortgage loans:
|
||||||||
Commercial
mortgage loans
|
$ | 151,001 | $ | 164,032 | ||||
Single-family
mortgage loans
|
63,887 | 70,607 | ||||||
214,888 | 234,639 | |||||||
Funds
held by trustees, including funds held for defeased loans
|
13,741 | 11,267 | ||||||
Accrued
interest receivable
|
1,392 | 1,538 | ||||||
Unamortized
discounts and premiums, net
|
(18 | ) | 90 | |||||
Other
|
(241 | ) | – | |||||
Loans,
at amortized cost
|
229,762 | 247,534 | ||||||
Allowance
for loan losses
|
(4,031 | ) | (3,707 | ) | ||||
$ | 225,731 | $ | 243,827 |
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
|||||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
Allowance
at beginning of period
|
$ | 4,016 | $ | 3,066 | $ | 3,707 | $ | 2,721 | ||||||||
Provision
for loan losses
|
248 | 449 | 566 | 796 | ||||||||||||
Charge-offs,
net of recoveries
|
(138 | ) | (3 | ) | (147 | ) | (5 | ) | ||||||||
Allowance
at end of period
|
$ | 4,126 | $ | 3,512 | $ | 4,126 | $ | 3,512 |
September
30,
2009
|
December
31, 2008
|
|||||||
Securitized
commercial mortgage loans
|
$ | 3,785 | $ | 3,527 | ||||
Securitized
single-family mortgage loans
|
246 | 180 | ||||||
4,031 | 3,707 | |||||||
Other
mortgage loans
|
95 | – | ||||||
$ | 4,126 | $ | 3,707 |
September
30, 2009
|
December
31, 2008
|
|||||||||||||||
Commercial
|
Single-family
|
Commercial
|
Single-family
|
|||||||||||||
Investment
in impaired loans
|
$ | 16,742 | $ | 3,958 | $ | 17,292 | $ | 3,501 | ||||||||
Allowance
for loan losses
|
3,785 | 246 | 3,527 | 180 | ||||||||||||
Investment
in excess of allowance
|
$ | 12,957 | $ | 3,712 | $ | 13,765 | $ | 3,321 |
Condensed
Statements of Operations
|
||||||||||||||||
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
|||||||||||||||
2009
|
2008
|
2009
|
2008
|
|||||||||||||
Interest
income
|
$ | 622 | $ | 903 | $ | 1,870 | $ | 3,392 | ||||||||
Fair
value adjustment
|
2,632 | (1,584 | ) | 2,652 | (5,846 | ) | ||||||||||
Other-than-temporary
impairment
|
– | (6,073 | ) | (1,417 | ) | (7,277 | ) | |||||||||
Other
expense
|
(6 | ) | (6 | ) | (25 | ) | (59 | ) | ||||||||
Net
income (loss)
|
$ | 3,248 | $ | (6,760 | ) | $ | 3,080 | $ | (9,790 | ) |
Condensed
Balance Sheets
|
||||||||
September
30,
2009
|
December
31, 2008
|
|||||||
Total
assets
|
$ | 16,410 | $ | 11,240 | ||||
Total
liabilities
|
$ | 21 | $ | 21 | ||||
Total
members’ capital
|
$ | 16,389 | $ | 11,219 |
September
30, 2009
|
December
31, 2008
|
|||||||||||||||
Carrying
Value
|
Weighted
Average Yield
|
Carrying
Value
|
Weighted
Average Yield
|
|||||||||||||
Non-Agency
MBS
|
$ | 6,612 | 8.07 | % | $ | 6,959 | 8.02 | % | ||||||||
Equity
securities of publicly traded companies
|
– | 3,441 | ||||||||||||||
6,612 | 10,400 | |||||||||||||||
Gross
unrealized gains
|
490 | 802 | ||||||||||||||
Gross
unrealized losses
|
(990 | ) | (1,335 | ) | ||||||||||||
6,112 | 9,867 | |||||||||||||||
Other
mortgage loans, net
|
2,188 | 2,657 | ||||||||||||||
Other
|
139 | 211 | ||||||||||||||
$ | 8,439 | $ | 12,735 |
September
30, 2009
|
||||||||||||
Collateral
Type
|
Balance
|
Weighted
Average Rate
|
Fair
Value of Collateral
|
|||||||||
Agency
MBS
|
$ | 516,627 | 0.39 | % | $ | 552,970 | ||||||
Securitization
financing bonds (see Note 9)
|
29,134 | 1.71 | % | 41,732 | ||||||||
$ | 545,761 | 0.46 | % | $ | 594,702 |
December
31, 2008
|
||||||||||||
Collateral
Type
|
Balance
|
Weighted
Average Rate
|
Fair
Value of Collateral
|
|||||||||
Agency
MBS
|
$ | 274,217 | 2.70 | % | $ | 300,277 | ||||||
Securitization
financing bonds
|
– | – | – | |||||||||
$ | 274,217 | 2.70 | % | $ | 300,277 |
Original
Maturity
|
September
30, 2009
|
December
31, 2008
|
||||||
30
days or less
|
$ | 280,759 | $ | 38,617 | ||||
31
to 60 days
|
75,680 | 187,960 | ||||||
61
to 90 days
|
7,577 | 47,640 | ||||||
Greater
than 90 days
|
181,745 | – | ||||||
$ | 545,761 | $ | 274,217 |
September
30, 2009
|
December
31, 2008
|
|||||||||||||||
Bonds
Outstanding
|
Range
of Interest Rates
|
Bonds
Outstanding
|
Range
of Interest Rates
|
|||||||||||||
Fixed-rate
classes
|
$ | 123,956 | 6.7% - 8.8 | % | $ | 149,598 | 6.6% - 8.8 | % | ||||||||
Variable-rate
classes
|
25,079 | 0.6 | % | 28,186 | 1.7 | % | ||||||||||
Accrued
interest payable
|
854 | 1,008 | ||||||||||||||
Unamortized
net bond premium and deferred costs
|
(1,705 | ) | (627 | ) | ||||||||||||
$ | 148,184 | $ | 178,165 | |||||||||||||
Range
of stated maturities
|
2024-2027 | 2024-2027 | ||||||||||||||
Estimated
weighted average life
|
3.3
years
|
2.6
years
|
||||||||||||||
Number
of series
|
3 | 3 |
September
30, 2009
|
December
31, 2008
|
|||||||
Discount
rate
|
25.0 | % | 36.5 | % | ||||
Annual
loss rate
|
1.5 | % | 0.8 | % | ||||
Prepayment
speed
(1)
|
20% CPY
|
100% CPY
|
(1)
|
CPR
with yield maintenance provision. 100% CPY assumes all loans
prepay at expiration of their prepayment lock-out period and pay yield
maintenance premium. 20% CPY assumes a CPR of 20% per annum on the pool
upon expiration of the prepayment lock-out
period.
|
·
|
Level
1 — Inputs are unadjusted, quoted prices in active markets for identical
assets or liabilities at the measurement date. The types of
assets and liabilities carried at Level 1 fair value generally are equity
securities listed in active
markets.
|
·
|
Level
2 — Inputs (other than quoted prices included in Level 1) are either
directly or indirectly observable for the asset or liability through
correlation with market data at the measurement date and for the duration
of the instrument’s anticipated life. Fair valued assets and
liabilities that are generally included in this category are Agency MBS,
which are valued based on the average of multiple dealer quotes that are
active in the Agency MBS market.
|
·
|
Level
3 — Inputs reflect management’s best estimate of what market participants
would use in pricing the asset or liability at the measurement
date. Consideration is given to the risk inherent in the
valuation technique and the risk inherent in the inputs to the
model. Generally, assets and liabilities carried at fair value
and included in this category are non-Agency MBS, and the obligation under
payment agreement liability.
|
Fair
Value Measurements
|
||||||||||||||||
Fair
Value
|
Level
1
|
Level
2
|
Level
3
|
|||||||||||||
Assets:
|
||||||||||||||||
Agency MBS
|
$ | 600,927 | $ | – | $ | 600,927 | $ | – | ||||||||
Non-Agency MBS
|
6,112 | – | – | 6,112 | ||||||||||||
Other
|
139 | – | – | 139 | ||||||||||||
Total assets carried at fair
value
|
$ | 607,178 | $ | – | $ | 600,927 | $ | 6,251 | ||||||||
Liabilities:
|
||||||||||||||||
Obligation under payment
agreement
|
$ | 9,095 | $ | – | $ | – | $ | 9,095 | ||||||||
Total liabilities carried at fair
value
|
$ | 9,095 | $ | – | $ | – | $ | 9,095 |
Level
3 Fair Values
|
||||||||||||||||
Other
Investments
|
Total
assets
|
Obligation
under payment agreement
|
||||||||||||||
Non-Agency
MBS
|
Other
|
|||||||||||||||
Balance
at June 30, 2009
|
$ | 5,813 | $ | 158 | $ | 5,971 | $ | (8,555 | ) | |||||||
Total
realized and unrealized gains (losses)
|
||||||||||||||||
Included in
earnings
|
– | – | – | (540 | ) | |||||||||||
Included in other comprehensive
income (loss)
|
383 | (14 | ) | 369 | – | |||||||||||
Purchases,
sales, issuances and other settlements, net
|
(84 | ) | (5 | ) | (89 | ) | – | |||||||||
Transfers
in and/or out of Level 3
|
– | – | – | – | ||||||||||||
Balance
at September 30, 2009
|
$ | 6,112 | $ | 139 | $ | 6,251 | $ | (9,095 | ) |
Level
3 Fair Values
|
||||||||||||||||
Other
Investments
|
Total
assets
|
Obligation
under payment agreement
|
||||||||||||||
Non-Agency
MBS
|
Other
|
|||||||||||||||
Balance
at December 31, 2008
|
$ | 6,259 | $ | 211 | $ | 6,470 | $ | (8,534 | ) | |||||||
Total
realized and unrealized gains (losses)
|
||||||||||||||||
Included in
earnings
|
– | – | – | (561 | ) | |||||||||||
Included in other comprehensive
income (loss)
|
199 | (31 | ) | 168 | – | |||||||||||
Purchases,
sales, issuances and other settlements, net
|
(346 | ) | (41 | ) | (387 | ) | – | |||||||||
Transfers
in and/or out of Level 3
|
– | – | – | – | ||||||||||||
Balance
at September 30, 2009
|
$ | 6,112 | $ | 139 | $ | 6,251 | $ | (9,095 | ) |
September
30, 2009
|
December
31, 2008
|
|||||||||||||||
Recorded
Basis
|
Fair
Value
|
Recorded
Basis
|
Fair
Value
|
|||||||||||||
Assets:
|
||||||||||||||||
Agency MBS
|
$ | 600,927 | $ | 600,927 | $ | 311,576 | $ | 311,576 | ||||||||
Securitized mortgage loans,
net
|
225,731 | 194,436 | 243,827 | 201,252 | ||||||||||||
Investment in joint
venture
|
8,174 | 8,174 | 5,655 | 5,595 | ||||||||||||
Other
investments
|
8,439 | 8,234 | 12,735 | 12,358 | ||||||||||||
Liabilities:
|
||||||||||||||||
Repurchase
agreements
|
545,761 | 545,761 | 274,217 | 274,217 | ||||||||||||
Securitization
financing
|
148,184 | 133,294 | 178,165 | 153,370 | ||||||||||||
Obligation under payment
agreement
|
9,095 | 9,095 | 8,534 | 8,534 |
September
30, 2009
|
December
31, 2008
|
|||||||||||||||
Fair
Value
|
Unrealized
Loss
|
Fair
Value
|
Unrealized
Loss
|
|||||||||||||
Unrealized
loss position for:
|
||||||||||||||||
Less than one
year:
|
||||||||||||||||
Agency MBS
|
$ | 29,906 | $ | 124 | $ | 98,171 | $ | 853 | ||||||||
Non-Agency MBS
|
20 | 1 | 3,719 | 937 | ||||||||||||
One year or
more:
|
||||||||||||||||
Non-Agency MBS
|
4,346 | 989 | 598 | 355 | ||||||||||||
$ | 34,272 | $ | 1,114 | $ | 102,488 | $ | 2,145 |
Dividend
per Share
|
||||||||||
Declaration
Date
|
Record
Date
|
Payment
Date
|
Common
|
Preferred
|
||||||
March 20, 2009
|
March
31, 2009
|
April
30, 2009
|
0.2300 | 0.2375 | ||||||
June 16, 2009
|
June
30, 2009
|
July
31, 2009
|
0.2300 | 0.2375 | ||||||
September 15, 2009
|
September
30, 2009
|
October
30, 2009
|
0.2300 | 0.2375 |
Preferred
|
||||||||
Series
D
|
Common
|
|||||||
December
31, 2008
|
4,221,539 | 12,169,762 | ||||||
Issuance
of shares under the CEOP
|
- | 1,392,250 | ||||||
Restricted
shares granted (see Note 14)
|
- | 10,000 | ||||||
September
30, 2009
|
4,221,539 | 13,572,012 |
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30, 2009
|
September
30, 2009
|
|||||||||||||||
Number
of Shares
|
Weighted-Average
Exercise Price
|
Number
of Shares
|
Weighted-
Average
Exercise
Price
|
|||||||||||||
SARs
outstanding at beginning of period
|
278,146 | $ | 7.27 | 278,146 | $ | 7.27 | ||||||||||
SARs
granted
|
– | – | – | – | ||||||||||||
SARs
forfeited or redeemed
|
– | – | – | – | ||||||||||||
SARs
exercised
|
– | – | – | – | ||||||||||||
SARs
outstanding at end of period
|
278,146 | $ | 7.27 | 278,146 | $ | 7.27 | ||||||||||
SARs
vested and exercisable
|
219,396 | $ | 7.37 | 219,396 | $ | 7.37 |
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
September
30, 2009
|
September
30, 2009
|
|||||||||||||||